BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu J, Lu L, Cheng X, Xie R, Chen Z, Li Y, Lin G, Liu J, Yang Y. Association between CD95L polymorphism and cervical cancer risk: evidence from a meta-analysis. Tumour Biol 2014;35:5137-42. [PMID: 24619598 DOI: 10.1007/s13277-014-1652-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Yu X, Li Y, Yu Y, Lei J, Wan G, Cao F. Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects. Onco Targets Ther 2016;9:2049-56. [PMID: 27103831 DOI: 10.2147/OTT.S102723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Tan SC, Ankathil R. Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes. Tumour Biol. 2015;36:6633-6644. [PMID: 26242271 DOI: 10.1007/s13277-015-3868-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
3 Nallapalle SR, Daripally S, Prasad VTSV. Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently. Tumor Biol 2015;36:2709-24. [DOI: 10.1007/s13277-014-2896-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]